In the present study the effects of the 48 - hour administration of granulocyte - macrophage colony - stimulating factor ( GM - CSF) ( 100 U / mL) or interleukin - 3 ( IL - 3) ( 100 U / mL) on the proliferative activity of leukemic cells and on the intracellular metabolism and cytotoxic efficacy of a subsequent 12 - hour application of cytosine arabinoside ( ara - C) at doses of 0. 1, 1. 0, 10. 0, and 100. 0 mumol / L were evaluated on bone marrow cells from 17 patients with acute myeloid leukemia.	"granulocyte - macrophage colony - stimulating factor	68	120	Gene_or_gene_product"	"GM - CSF	123	131	Gene_or_gene_product"	"interleukin - 3	150	165	Gene_or_gene_product"	"IL - 3	168	174	Gene_or_gene_product"	"leukemic cells	223	237	Cell"	"intracellular	249	262	Immaterial_anatomical_entity"	"cytosine arabinoside	338	358	Chemical"	"ara - C	361	368	Chemical"	"bone marrow cells	440	457	Cell"	"patients	466	474	Organism"	"acute myeloid leukemia	480	502	Cancer"	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 68, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""GM - CSF"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 3"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemic cells"", ""start_span"": 223, ""end_span"": 237, ""type"": ""Cell""}, {""token"": ""intracellular"", ""start_span"": 249, ""end_span"": 262, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cytosine arabinoside"", ""start_span"": 338, ""end_span"": 358, ""type"": ""Chemical""}, {""token"": ""ara - C"", ""start_span"": 361, ""end_span"": 368, ""type"": ""Chemical""}, {""token"": ""bone marrow cells"", ""start_span"": 440, ""end_span"": 457, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 466, ""end_span"": 474, ""type"": ""Organism""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 480, ""end_span"": 502, ""type"": ""Cancer""}]"
While in control specimens are ara - C dose - dependent increase in 3H - ara - C uptake was accompanied by a corresponding rise in intracellular ara - C - 5 ' triphosphate ( ara - CTP) levels, ara - CTP concentrations were not increased after GM - CSF or IL - 3 exposure, resulting in a higher ara - C to ara - CTP ratio over controls.	"specimens	17	26	Cell"	"ara - C	31	38	Chemical"	"3H - ara - C	68	80	Chemical"	"intracellular	131	144	Immaterial_anatomical_entity"	"ara - C - 5 ' triphosphate	145	171	Chemical"	"ara - CTP	174	183	Chemical"	"ara - CTP	193	202	Chemical"	"GM - CSF	243	251	Gene_or_gene_product"	"IL - 3	255	261	Gene_or_gene_product"	"ara - C	294	301	Chemical"	"ara - CTP	305	314	Chemical"	"[{""token"": ""specimens"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""ara - C"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""3H - ara - C"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ara - C - 5 ' triphosphate"", ""start_span"": 145, ""end_span"": 171, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical""}, {""token"": ""GM - CSF"", ""start_span"": 243, ""end_span"": 251, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 255, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}, {""token"": ""ara - C"", ""start_span"": 294, ""end_span"": 301, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 305, ""end_span"": 314, ""type"": ""Chemical""}]"
EXPERIMENTAL DESIGN: In this study all of the major members of the matrix metalloproteinase ( MMP - 1, MMP - 2, MMP - 3, MMP - 7, MMP - 9, MMP - 13, MT1 - MMP and MT2 - MMP) / tissue inhibitor of matrix metalloproteinase ( TIMP - 1, TIMP - 2, and TIMP - 3) system have been investigated by immunohistochemistry in a series ( n = 90) of stage III ( Dukes ' C) colorectal cancers.	"MMP - 1	94	101	Gene_or_gene_product"	"MMP - 2	103	110	Gene_or_gene_product"	"MMP - 3	112	119	Gene_or_gene_product"	"MMP - 7	121	128	Gene_or_gene_product"	"MMP - 9	130	137	Gene_or_gene_product"	"MMP - 13	139	147	Gene_or_gene_product"	"MT1 - MMP	149	158	Gene_or_gene_product"	"MT2 - MMP	163	172	Gene_or_gene_product"	"TIMP - 1	223	231	Gene_or_gene_product"	"TIMP - 2	233	241	Gene_or_gene_product"	"TIMP - 3	247	255	Gene_or_gene_product"	"[{""token"": ""MMP - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 3"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 7"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 13"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""MT1 - MMP"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""MT2 - MMP"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 1"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 2"", ""start_span"": 233, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP - 3"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene_or_gene_product""}]"
Mutant mice lacking both cyclin - dependent kinase ( CDK) inhibitors p18 ( Ink4c) and p27 ( Kip1) develop a tumor spectrum reminiscent of human multiple endocrine neoplasia ( MEN) syndromes.	"mice	7	11	Organism"	"cyclin - dependent kinase	25	50	Gene_or_gene_product"	"CDK	53	56	Gene_or_gene_product"	"p18	69	72	Gene_or_gene_product"	"Ink4c	75	80	Gene_or_gene_product"	"p27	86	89	Gene_or_gene_product"	"Kip1	92	96	Gene_or_gene_product"	"tumor	108	113	Cancer"	"human	138	143	Organism"	"multiple endocrine neoplasia	144	172	Cancer"	"MEN	175	178	Cancer"	"[{""token"": ""mice"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""cyclin - dependent kinase"", ""start_span"": 25, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4c"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""multiple endocrine neoplasia"", ""start_span"": 144, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""MEN"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Cancer""}]"
Interleukin - 2 administration was followed by a significant increase in total lymphocytes, CD4 +, CD8 +, CD16 + 56 + ( NK) cells, IL - 6, IL - 12, and CRP ( from P < 0. 04 to P < 0. 000) but no change in IL - 10 and TGFbeta1 during clinical benefit.	"Interleukin - 2	0	15	Gene_or_gene_product"	"lymphocytes	79	90	Cell"	"CD4	92	95	Gene_or_gene_product"	"CD8	99	102	Gene_or_gene_product"	"CD16	106	110	Gene_or_gene_product"	"56	113	115	Gene_or_gene_product"	"IL - 6	131	137	Gene_or_gene_product"	"IL - 12	139	146	Gene_or_gene_product"	"CRP	152	155	Gene_or_gene_product"	"IL - 10	205	212	Gene_or_gene_product"	"TGFbeta1	217	225	Gene_or_gene_product"	"[{""token"": ""Interleukin - 2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocytes"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""CD4"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD16"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""56"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRP"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta1"", ""start_span"": 217, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}]"
Semaphorin 7A ( Sema7A) is a membrane - linked semaphorin that is expressed by human keratinocytes, and we have shown that Sema7A binds to human melanocytes through beta1 - integrins and the Plexin C1 receptor.	"Semaphorin 7A	0	13	Gene_or_gene_product"	"Sema7A	16	22	Gene_or_gene_product"	"membrane	29	37	Cellular_component"	"semaphorin	47	57	Gene_or_gene_product"	"human	79	84	Organism"	"keratinocytes	85	98	Cell"	"Sema7A	123	129	Gene_or_gene_product"	"human	139	144	Organism"	"melanocytes	145	156	Cell"	"beta1 - integrins	165	182	Gene_or_gene_product"	"Plexin C1 receptor	191	209	Gene_or_gene_product"	"[{""token"": ""Semaphorin 7A"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sema7A"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cellular_component""}, {""token"": ""semaphorin"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""keratinocytes"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""Sema7A"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""melanocytes"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""beta1 - integrins"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexin C1 receptor"", ""start_span"": 191, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
In cultured stable Grm1 - mouse - melanocytic clones, as well as an metabotropic glutamate receptor 1 ( Grm1) expressing human melanoma cell line, C8161, stimulation of Grm1 by its agonist led to the activation of AKT, while preincubation with Grm1 - antagonist abolished Grm1 - agonist - induced AKT activation.	"Grm1	19	23	Gene_or_gene_product"	"mouse	26	31	Organism"	"melanocytic clones	34	52	Cell"	"glutamate receptor 1	81	101	Gene_or_gene_product"	"Grm1	104	108	Gene_or_gene_product"	"human	121	126	Organism"	"Grm1	169	173	Gene_or_gene_product"	"AKT	214	217	Gene_or_gene_product"	"Grm1	244	248	Gene_or_gene_product"	"Grm1	272	276	Gene_or_gene_product"	"AKT	297	300	Gene_or_gene_product"	"[{""token"": ""Grm1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""melanocytic clones"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""glutamate receptor 1"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""Grm1"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 244, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 297, ""end_span"": 300, ""type"": ""Gene_or_gene_product""}]"
RESULTS: AQP1, 3 - 5, and 10 - 12 were expressed in human breast cancer and / or normal breast tissues, and AQP1 and 3 - 5 exhibited differential expression.	"AQP1	9	13	Gene_or_gene_product"	"3	15	16	Gene_or_gene_product"	"5	19	20	Gene_or_gene_product"	"10	26	28	Gene_or_gene_product"	"12	31	33	Gene_or_gene_product"	"human	52	57	Organism"	"breast cancer	58	71	Cancer"	"breast tissues	88	102	Tissue"	"AQP1	108	112	Gene_or_gene_product"	"3	117	118	Gene_or_gene_product"	"5	121	122	Gene_or_gene_product"	"[{""token"": ""AQP1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 15, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 19, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""10"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""12"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""breast tissues"", ""start_span"": 88, ""end_span"": 102, ""type"": ""Tissue""}, {""token"": ""AQP1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 117, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 121, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
By modulating beta - catenin levels in a mouse model of melanoma that is based on melanocyte - specific Pten loss and Braf ( V600E) mutation, we demonstrate that beta - catenin is a central mediator of melanoma metastasis to the lymph nodes and lungs.	"beta - catenin	14	28	Gene_or_gene_product"	"mouse	41	46	Organism"	"melanoma	56	64	Cancer"	"melanocyte	82	92	Cell"	"Pten	104	108	Gene_or_gene_product"	"Braf	118	122	Gene_or_gene_product"	"V600E	125	130	Amino_acid"	"beta - catenin	162	176	Gene_or_gene_product"	"melanoma	202	210	Cancer"	"lymph nodes	229	240	Multi"	"lungs	245	250	Organ"	"[{""token"": ""beta - catenin"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""melanocyte"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""Pten"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Braf"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""V600E"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Amino_acid""}, {""token"": ""beta - catenin"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Multi""}, {""token"": ""lungs"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Organ""}]"
To evaluate the concept that localized delivery of angiogenic factors via virus - mediated gene transfer may be useful in the treatment of ischemic disorders, the replication - deficient adenovirus ( Ad) vector AdCMV. VEGF165 ( where CMV is cytomegalovirus and VEGF is vascular endothelial growth factor) containing the cDNA for human VEGF165, a secreted endothelial cell - specific angiogenic growth factor, was constructed.	"adenovirus	187	197	Organism"	"Ad	200	202	Organism"	"VEGF165	218	225	Gene_or_gene_product"	"CMV	234	237	Organism"	"cytomegalovirus	241	256	Organism"	"VEGF	261	265	Gene_or_gene_product"	"vascular endothelial growth factor	269	303	Gene_or_gene_product"	"cDNA	320	324	Cellular_component"	"human	329	334	Organism"	"VEGF165	335	342	Gene_or_gene_product"	"endothelial cell	355	371	Cell"	"[{""token"": ""adenovirus"", ""start_span"": 187, ""end_span"": 197, ""type"": ""Organism""}, {""token"": ""Ad"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Organism""}, {""token"": ""VEGF165"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}, {""token"": ""CMV"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Organism""}, {""token"": ""cytomegalovirus"", ""start_span"": 241, ""end_span"": 256, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 269, ""end_span"": 303, ""type"": ""Gene_or_gene_product""}, {""token"": ""cDNA"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 329, ""end_span"": 334, ""type"": ""Organism""}, {""token"": ""VEGF165"", ""start_span"": 335, ""end_span"": 342, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 355, ""end_span"": 371, ""type"": ""Cell""}]"
9E3 / CEF4 was slightly mitogenic for CEF, causing a doubling of [ 3H] thymidine uptake when added to serum - starved CEF. 9E3 / CEF4 was found associated not only with the cell and in the culture medium of Rous sarcoma virus - transformed CEF but also with the extracellular matrix.	"9E3	0	3	Gene_or_gene_product"	"CEF4	6	10	Gene_or_gene_product"	"CEF	38	41	Cell"	"serum	102	107	Organism_substance"	"CEF	118	121	Cell"	"9E3	123	126	Gene_or_gene_product"	"CEF4	129	133	Gene_or_gene_product"	"cell	173	177	Cell"	"Rous sarcoma virus	207	225	Organism"	"CEF	240	243	Cell"	"extracellular matrix	262	282	Cellular_component"	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism_substance""}, {""token"": ""CEF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""9E3"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 207, ""end_span"": 225, ""type"": ""Organism""}, {""token"": ""CEF"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 262, ""end_span"": 282, ""type"": ""Cellular_component""}]"
The principal types of tumors were plasmacytomas secreting immunoglobulin and novel lymphomas that expressed markers such as Sca - 1, CD4, Thy - 1, CD34 and CD45 ( B220), consistent with an origin very early in B - lymphoid development.	"tumors	23	29	Cancer"	"plasmacytomas	35	48	Cancer"	"immunoglobulin	59	73	Gene_or_gene_product"	"lymphomas	84	93	Cancer"	"Sca - 1	125	132	Gene_or_gene_product"	"CD4	134	137	Gene_or_gene_product"	"Thy - 1	139	146	Gene_or_gene_product"	"CD34	148	152	Gene_or_gene_product"	"CD45	157	161	Gene_or_gene_product"	"B220	164	168	Gene_or_gene_product"	"B - lymphoid	211	223	Cell"	"[{""token"": ""tumors"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""plasmacytomas"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""immunoglobulin"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphomas"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""Sca - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD4"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""Thy - 1"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD45"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""B220"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - lymphoid"", ""start_span"": 211, ""end_span"": 223, ""type"": ""Cell""}]"
For the purpose of investigating the relationship between the metastatic potential of the tumor as well as the expression of nm23 - H1 mRNA, and for determing the location of the positive sites in the cells, tumor metastasis suppressor gene nm23 - H1 in human hepatocellular carcinoma ( and the nonneoplastic area surrounding the tumor) was detected by in situ hybridization using digoxiginin - labeled nm23 - H1 antisense complementary RNA probe.	"tumor	90	95	Cancer"	"nm23 - H1	125	134	Gene_or_gene_product"	"cells	201	206	Cell"	"tumor	208	213	Cancer"	"nm23 - H1	241	250	Gene_or_gene_product"	"human	254	259	Organism"	"hepatocellular carcinoma	260	284	Cancer"	"nonneoplastic area	295	313	Multi"	"tumor	330	335	Cancer"	"digoxiginin	381	392	Chemical"	"nm23 - H1	403	412	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 260, ""end_span"": 284, ""type"": ""Cancer""}, {""token"": ""nonneoplastic area"", ""start_span"": 295, ""end_span"": 313, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 330, ""end_span"": 335, ""type"": ""Cancer""}, {""token"": ""digoxiginin"", ""start_span"": 381, ""end_span"": 392, ""type"": ""Chemical""}, {""token"": ""nm23 - H1"", ""start_span"": 403, ""end_span"": 412, ""type"": ""Gene_or_gene_product""}]"
